SQZ Biotechnologies Company
SQZB
$0.04
$0.01242.86%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -4.40% | 24.58% | 15.93% | -14.59% | -0.86% |
| Total Depreciation and Amortization | -3.05% | -16.56% | 10.90% | 25.02% | 2.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 193.10% | -54.72% | -65.04% | -23.75% | -14.56% |
| Change in Net Operating Assets | 86.02% | 44.75% | -137.72% | 13.04% | -11.46% |
| Cash from Operations | 33.58% | 25.42% | -16.34% | 1.24% | -4.72% |
| Capital Expenditure | 100.00% | 41.25% | 71.49% | -- | -22.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 113.27% | 235.00% | 66.49% | -- | -22.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 18.64% | 291.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 18.64% | 291.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.92% | 12.63% | -15.72% | 1.02% | -2.45% |